PEDF has been shown to reduce inflammation by inhibiting NF-κB signaling and reducing the secretion of pro-inflammatory cytokines such as IL-6 and TNF-α, which are key players in tumor-associated inflammation. Here, SERPINF1 is linked to neoplasm.